TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:56
Aptorum Group Ltd ( APM ) https://www.aptorumgroup.com
0.86USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United Kingdom
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-65.46%
APM
SPY
32.66%
-95.00%
APM
SPY
108.59%
-99.40%
APM
SPY
302.52%
APM
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
4.46
5.86
0.06
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.35
9.44
0.29
-36.27
0.00
-0.41
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
6.8592
-86.78
-118.63
0.69
Other Earnings and Cash Flow Stats:
Aptorum Group Ltd ( APM ) Net Income TTM ($MM) is -5.65
Aptorum Group Ltd ( APM ) Operating Income TTM ($MM) is -21.06
Aptorum Group Ltd ( APM ) Owners' Earnings Annual ($MM) is -1488.90
Aptorum Group Ltd ( APM ) Current Price to Owners' Earnings ratio is -0.01
Aptorum Group Ltd ( APM ) EBITDA TTM ($MM) is -18.81
Aptorum Group Ltd ( APM ) EBITDA Margin is 0.00%
Capital Allocation:
Aptorum Group Ltd ( APM ) has paid 0.00 dividends per share and bought back -1.332076 million shares in the past 12 months
Aptorum Group Ltd ( APM ) has reduced its debt by 3.756665 million USD in the last 12 months
Capital Structure:
Aptorum Group Ltd ( APM ) Interest-bearing Debt ($MM) as of last quarter is 3
Aptorum Group Ltd ( APM ) Annual Working Capital Investments ($MM) are 10
Aptorum Group Ltd ( APM ) Book Value ($MM) as of last quarter is 15
Aptorum Group Ltd ( APM ) Debt/Capital as of last quarter is 13%
Other Balance Sheet Stats:
Aptorum Group Ltd ( APM ) has 2 million in cash on hand as of last quarter
Aptorum Group Ltd ( APM ) has 2 million of liabilities due within 12 months, and long term debt 3 as of last quarter
Aptorum Group Ltd ( APM ) has 5 common shares outstanding as of last quarter
Aptorum Group Ltd ( APM ) has 0 million USD of preferred stock value
Academic Scores:
Aptorum Group Ltd ( APM ) Altman Z-Score is -6.64 as of last quarter
Aptorum Group Ltd ( APM ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
Aptorum Group Ltd ( APM ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Aptorum Group Ltd ( APM ) for the amount of $ on
23.71% of Aptorum Group Ltd ( APM ) is held by insiders, and 1.46% is held by institutions
Aptorum Group Ltd ( APM ) went public on 2018-12-18
Other Aptorum Group Ltd ( APM ) financial metrics:
FCF:-15.56
Unlevered Free Cash Flow:-18.52
EPS:2.06
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:42.86
Beta:0.69
Buffet's Owners Earnings:-1488.90
Price to Owner's Earnings:-0.01
About Aptorum Group Ltd ( APM ) :
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.